While low-dose CycD treatment showed reducing in MDA and NO levels compared to CIA group, this reduction did not reach statistical significance.
← all excerpts
Cyclovirobuxine D attenuates collagen-induced arthritis by inhibiting PI3K/AKT pathway and macrophage polarization.
1
—
—